LAUREN SEALES: Open Payments
NPI 1790408979 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,914 in 139 payments from 17 companies in 2025. Trend: 2023 $1,781 · 2024 $2,946 · 2025 $2,914
Food & beverage: $2,830Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $512 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $434 |
| Janssen Biotech, Inc. | 22 | $431 |
| Aimmune Therapeutics, Inc. | 18 | $340 |
| Madrigal Pharmaceuticals | 11 | $294 |
| Janssen Scientific Affairs, LLC | 2 | $190 |
| Ipsen Biopharmaceuticals, Inc | 9 | $169 |
| Phathom Pharmaceuticals, Inc. | 5 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $145 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, RINVOQ, ZENPEP, IQIRVO, VOQUEZNA, VOWST.
Industry payments across TX — which companies pay providers there.
